BioPharma Pharma QC
The PD-(L)1 x VEGF Bispecific Race: Every APAC Programme in the Clinic, Counted
When the ESMO Congress opens in Madrid on 23 October, one drug class will be hard to miss. Two days in, on the evening of Sunday 25 October, the Presidenti...
October 16, 2026 | Analysis
NueCell Bio Joins CIRM Partnership to Accelerate Cell and Gene Therapies from Discovery to GMP Readiness
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced it has joined the ...
October 16, 2026 | News
Suvoda Expands Sofia AI Assistant Across New Clinical Trials to Accelerate Study Operations
Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails. Sofia help...
October 13, 2026 | News
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, announced a strategic partnership with Waters Corporation, a global lea...
October 14, 2026 | News
Australia’s VVMF Secures TGA GMP Licence for Viral Vector Manufacturing
Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO) advises...
September 18, 2026 | News
Ecolab Life Sciences Opens New Resin Manufacturing Facility in China
Demand for advanced purification solutions is growing as industries look to improve performance while using less water and fewer natural resources. Industr...
September 16, 2026 | News
Thermo Fisher Scientific Launches 250-Litre Heratherm Environmental Chambers for Stability Testing and Quality Control
Thermo Fisher Scientific has introduced the Thermo Scientific™ Heratherm™ Environmental Chambers with a 250-litre capacity, expanding its envir...
September 16, 2026 | News
CelluPro Becomes First Chinese Cell Culture Media Supplier to Secure EXCiPACT GMP Certification
CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certif...
September 09, 2026 | News
Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain
Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...
September 02, 2026 | News
WuXi XDC Achieves GMP Release for First Overseas Bioconjugate Manufacturing Facility in Singapore
WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...
August 19, 2026 | News
ACROBiosystems Secures Japan PMDA Confirmation for GMP-Grade IL-15 Used in Cell Therapy Manufacturing
ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号...
July 16, 2026 | News
The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
A control room that thinks it knows what happens next Walk the mezzanine above a modern biologics suite in Singapore, Songdo or Hyderabad and the change i...
July 13, 2026 | Analysis
APAC's Peptide-Capacity Gamble
For most of pharmaceutical history, the hard part was finding a molecule that worked. The GLP-1 class inverted that logic. The science arrived first &mdash...
July 09, 2026 | Analysis
Takeda Partners with Insilico Medicine in Up to $600M AI Drug Discovery Collaboration
Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas Insilico Medicine ("Insilico" HKEX:3696),...
July 03, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
